Phytochemical Screening and In Vitro Antibacterial Acitivity of Methanol and Aqueous Extracts of Acalypha Racemosa Leaves
Hammuel C.1*, Anyim B. P.2, Raplong
H.H.3, Inekwe U.V.1
and Batari M.L.1
1Department of Basic Research, National
Research Institute for Chemical Technology, Zaria, Nigeria.
2Textile Department, National Research
Institute for Chemical Technology, Zaria, Nigeria.
3Department of Environmental Engineering,
National Research Institute for Chemical Technology, Zaria, Nigeria
*Corresponding Author E-mail: chrizoy2k@yahoo.com
ABSTRACT:
The extracts obtained from this
plant were subjected to be screened for phytochemical
constituents and in vitro
investigation of methanol and aqueous extracts. The phytochemical
screening revealed the presence of saponins, phlabatanins, flavonoids, and
alkaloids. Glycoside and cardiac glycoside, tannins and sterols were in traced
amount. The in vitro antibacterial
investigation of the crude extract was conducted. The studies showed that the
plant contains compounds that have antibacterial activity. The extracts
revealed greater potential against the test bacteria with zones of inhibition
ranging from 20-30mm for methanol extract in the order Escherichia coli>Klebsiella penumoniae>Proteus mirabilis>Bacillus subtilis>Pseudomonas aeruginosa
and 18-27mm for aqueous extract in the order Escherichia coli> Bacillus subtilis> Klebsiella penumoniae and Pseudomonas aeruginosa>
Proteus mirabilis. All the bacteria were more susceptible to methanol
extract than the aqueous extract as indicated in the zones of inhibition with
exception of Pseudomonas aeruginosa in which there was no inhibition. The
aqueous extract had effect on all the test bacteria although having zones of
inhibition lower than the methanol extract.
The MIC of both the extracts range from 12.5-50mg/ml and the MBC range
from 25-100mg/ml. Escherichia coli
was more susceptibility to the both extracts and less was seen in the case of
aqueous extract against Proteus
mirabilis.
KEYWORDS: Acalypha, phytochemical,
antibacterial, inhibition, MIC and MBC.
INTRODUCTION:
The
used of plants and herbs in the treatment of pathogenic diseases in most of the
developing world. Researchers around the world have been engaged in the
findings and formulation of new drugs; this is as a result of every day
challenge of drug resistivity by microorganisms (Maureer-Gimes
et al., 1996). Incidents due to drug
resistant microorganisms and the emergence of unknown disease causing microbes,
posed enormous global public health concern (Iwu,
1993).This resistance can be due to inappropriate administration of drugs
commonly used on the treatment of these infectious diseases (Afolayan and Aliero, 2006).
Furthermore some antibiotics have serious undesirable side effect which limit
their application, so there is serious need to develop new antimicrobial agents
that are very effective with minimal unwanted side effect and higher plants
represent a potential source of novel antibiotic prototypes (Afolayan, 2003).
In recent years, there has been a gradual
revival of interest in the use of medicinal plants in developing countries because herbal medicines have been reported
safe and without any adverse side effect especially when compared with
synthetic drugs (Ezekiel et al.,
2009). Also, there has been little or no report of any form of microbial
resistance during the use and administration of herbal medicines (Stephen et
al., 2009). More importantly in Africa, particularly West Africa, new drugs
are often beyond the reach of the poor such that up to 80% of the population
use medicinal plants as remedy against infections and diseases
(Kirby, 1996; Hostettmann and Maston,
2002).
The used of medicine medicinal plants all
over the world predates the introduction of antibiotics and other modern drugs.
There is a need for everyday research on the development and formulation of new
drugs to counterfeit/curtail resistant of pathogenic microorganisms to
antibiotics (Hammuel et al; 2011). Apart from employing the medicinal plants (herbs) for
treatment of pathogenic disease it can be used to treat various ailments that
are not directly caused by microorganisms such as jaundice, fever, rheumatism,
epilepsy (Igbinosa, et al; 2009). The world health organization has recorded over
20,000 species of the plant Acalypha with medicinal properties providing treatment for
such complaints as pneumonia, ulcers, diarrhoea,
bronchitis, cold and diseases of the respiratory tract (Flavia
et al ; 2088).
Acalypha plant is a genus of the family Euphorbiaceae
and grows as an annual bedding plant (Oladunmoye,
2006). There are about 570 species, a large proportion of which are weeds that
is open to forest zones of Nigeria and it is widely spread across tropics of
Africa for example the macrophylla, hoffamanii, godseffiana, macafeeana, hispida, marginata and racemosa are
peculiar cultivars within Nigeria (Oladunmoye, 2006; Yusha’u et al., 2008; Iniaghe
et al., 2009). Euphorbiaceae species are
large, fast-growing, evergreen shrub provides a continuous splash of colour in the landscape with the bronze red to muted red, 4
to 8 inch long, heart-shaped leaves available in varying mottled combinations
of green, purple, yellow, orange, pink, or white, depending upon cultivar
(Gilman, 1999). Others are ornamental plants or called as horticultural shrubs
(Iniaghe et al;
2009). Some of the species Acalypha are known to be used in traditional medicine. Musa et al; 2000 reported the medicinal
important of the A. racemosa
to have exhibited the antibacterial activity. Iniaghe
et al; 2009 also reported the used of
the decocted leave of the plant by traditional practitioners in Ilorin
metropolis, Nigeria to treat liver disorders and other disease condition which
resulted in jaundice. The aqueous extract of the leaves of A. racemosa has also been reported to
have hepaprotective effect in caborn
tetrachloride induced liver of rats (Iniaghe et al; 2008).
MATERIALS AND METHOD:
Preparation of the extract:
Fresh leaves of A. racemosa,
was collected from parish house Zaria and was identified by the department of
Botany Ahmadu Bello University, Zaria, Nigeria.
The collected leaves were dried
at 40oC using Gallenhamp drying cabinet.
The dried leaves were grinded into powdered form using mortar and pestle. 300gm
of the powdered sample was dissolved in 400ml each of distilled water and
methanol, the process was allowed to stay for 2 days to ensure proper
extraction. The mixture was then filtered using Whatman No. 1 filter paper. The
solvents were evaporated using water bath at temperature of 50oC in
order to concentrate the extract.
The phytochemical screening of the plant
extracts:
Conventional standard protocols
(Odebiyi & Sofowora,
1978; Trease & Evans, 1983) for detecting the
presence of different chemical constituents in the plant extract were employed.
The tests for the secondary metabolites viz. tannins, alkaloids, saponins, glycosides, flavonoids,
cardiac glycoside, phlabatannins, and steroids were
carried out.
Test for tannins
(FeCl3 test):
About 0.5g of the dried powdered sample was
dissolved in 20ml of distilled water in a test tube, boiled and filtered. To
the filtrate few drops of 1.0% Iron II chloride solution was added and observed
for a blue-green precipitate.
Test for flavonoid:
The test was conducted in two different
ways or methods:
To 1.0ml of the extract 1.0ml of 10% lead
acetate was added, and observed for yellow precipitation.
And to 1.0ml of the extract of the plant
1.0ml of dilute NaOH was added and observed for
precipitation.
Test for
alkaloids:
Two different reagents (Wagner’s and
Mayer’s reagents) were used to ascertain the presence of alkaloids in the
sample:
Two (2.0) ml of the mixed and shook with
10.0ml of 2% HCl on a steam bath and filtered. The
filtrate was divided into two equal portions. To the first portion Wagner’s
reagent was added in drops and observed for a brown precipitate. To the second
portion of the filtrate, Mayer’s reagent was added also in drops and observed
for white to yellow or creamy with precipitate.
Test for saponins (frothing test):
1.0ml of extract was boiled with 5.0ml of
distilled water for five (5) minutes and decanted while still hot. Then was
filtered, and 1.0ml of the filtrate was diluted with 4.0ml of distilled water
and was shook vigorously. It was observed on standing for stable froth.
Test for glycoside
(fecl3 test):
To 5.0ml of the extract in a test tube
2.5ml of dilute H2SO4 acid was added and boiled in water
bath for 15 minutes. It was cooled and neutralized with 20% KOH solution.5ml of
a mixture of Fehling’s solution A and B were added, boiled and observed for
reddish brown colour at the interphase.
Test for cardiac
glycoside:
To 1.0ml of the extract 8% of methanol was
added and mixed with 1.0ml of 2% solution 3, 5-dinitrobenzoic acid in 95%
alcohol. The solution was made alkaline with 5% NaOH.
It was observed for violet colour which faded through
reddish brown to brownish yellow.
The test
organisms:
The test organisms for the study are
bacteria which include the Bacillus subtilis, Pseudomonas aeruginosa,
Proteus mirabilis, Escherichia coli and
Klebsiella pneumoniae.
These organisms were isolated from patients in the Department of Microbiology, Ahmadu Bello University Teaching Hospital (ABUTH), Zaria,
Nigeria. They were transported in slants to National Research Institute for
Chemical Technology, Zaria, Nigeria.
The antimicrobial
screening of the extracts:
The
antimicrobial activity of the plant extracts were determined using agar well
diffusion method as described by Reuben et
al 2008. The bacterial and the fungal isolates collected in prepared slants
of nutrients agar were sub-cultured into prepared nutrients broth and incubated
at 37oC for 24hours and standardized to 0.5 Mc-Farland
scale (108cfu/mL) in a prepared normal
saline. The cell suspensions were swabbed onto nutrient agar plates MacConkey agar for Klebsiella pneumoniae. Wells were then bored into the plates of
the inoculated organism using sterile cork-borer of 6mm in diameter. 1.0g of
each of the methanol and aqueous concentrated extracts were constituted into
10mL of their respective solvents of extraction (methanol and water) to obtain
the initial concentration of 100mg/mL. Then 1.0ml of
the concentration of the both extracts was introduced to fill the wells
created, allowed to stand for 30 minutes at room temperature for proper
diffusion and then incubated at 37oC for 24hours in an incubator.
Controls were also set up in parallel, but using the solvents of extractions
only. After the incubation 24hours the plates were observed for zones of
inhibition and recorded in millimeter (mm).
Minimum inhibitory
concentration (MIC):
The MIC of the crude extracts was
determined using the method as given by Canales et al 2011. 100mg/ml of each of the extracts were reconstituted
into nutrient broth in test tubes and the 100mg/ml was taken as the initial
concentration. Four more tubes of 5ml nutrient broth were set up and 5ml of 100mg/ml
of the extract was taken and used for two-fold dilution of the four tubes of
nutrient broth forming concentrations of 100mg/ml, 50mg/ml, 25mg/ml, 12.5mg/ml
and 6.25mg/ml.
Normal saline was used again to prepare
turbid suspensions of the microbes; the dilution was done continuously and
incubated at 37oC for 30 minutes. Until the turbidity matched that
0.5 Mcfarland’s standard by visual comparison. At
that point the of cells is assumed to be 1.5 x 108cfu/ml. 0.1ml of
the cell suspension was inoculated into each of the tubes with the varied
concentrations of extracts. All the tubes were incubated at 37oC for
24 hours. The tube with the lowest concentration which has no growth
(turbidity) of the microbes was taken to be the minimum inhibitory concentration
(MIC).
RESULTS
Table 1: The phytochemical
screening of the extract
|
Components |
Methanolic extract |
Aqueous extract |
|
Saponins |
+ |
+ |
|
Flavonoids |
+ |
+ |
|
Alkaloids |
+ |
+ |
|
Sterols
(Steroid nucleus) |
T |
+ |
|
Cardiac
glycoside |
- |
- |
|
Tannins |
T |
+ |
|
Glycoside |
- |
- |
KEY:
+ =
Present, - = Absent, T = Trace
Minimum
bactericidal concentration (MBC):
The minimum bactericidal concentration
(MBC) of the plant extract against the microbes was determined using the method
of Ravikumar et
al., 2007. The tubes of the MIC that showed no growth of the microbes were
sub-cultured by streaking using sterile wire loop on nutrient agar plates, MacConkey agar plate for Klebsiella pneumoniae. The plates were incubated at
37oC for 24 hours. MBC is the lowest concentration of the extract
that showed not any colony growth on the agar plates. It was obtained and
recorded.
Figure 1:The
antibacterial susceptibility of the extracts showing the zones of inhibitions
Figure 2:The
minimum inhibitory concentration (MIC) of the extracts against the bacteria
Figure3:The
minimum bactericidal concentration (MBC) of the extracts against the bacteria.
Table 2: The set of controls showing the
zones of inhibition in mm
|
Test Organisms |
Negative (solvent) control, methanol |
Positive(drug)
control, Tetracycline (50 mg/ml |
|
Bacillus subtilis |
2 |
46 |
|
Pseudomonas aeruginosa |
0 |
0 |
|
Proteus mirabilis |
0 |
39 |
|
Escherichia coli |
3 |
41 |
|
Klesiella pneumoniae |
2 |
36 |
DISCUSSION:
The phytochemical
screening of the extracts revealed the presence of saponins,
alkaloids, phlabatanins, flavonoids.
Steroids and tannins were found in trace amounts as presented in Table 1. In
the screening for the biological active compounds there was no information
about glycoside and cardiac glycoside. These results agreed with the report of Iniaghe et al,
2009. These secondary metabolites exert antimicrobial activity in different
mechanism; flavonoids have also exhibited a wide
range of biological activities; such as antimicrobial, antioxidant,
anti-inflammatory, anti-agionic, analgesic, anti-allergics and cytostatic
properties (Hodek et al., 2002). Tannins has been
found to react with praline-rich protein to from irreversible complexes
(Shimada, 2006), resulting in the inhibition of cell protein synthesis. Herbs
that have tannins as their major components are astringent in nature and are
used for treating intestinal disorders such as diarrhea and dysentery (Dharmananda , 2003). The presence of saponins
lend credence to the use of this plant in managing inflammation (Quinlan et
al., 2000) worked on steroidal extracts from medical plants which exhibited
antibacterial activities on some bacterial isolates.
The zones of clearance of the pathogens by
the extracts as seen in figure 1 indicated that both of the extracts had good
activity against the pathogens. This agreed with the report of Verastegui et al.,
2008 that ethanol extract is active against range of bacteria including fungi. Pseudomonas aeruginosa
in this study was resistant methanol extract this could be as a result of
inadequate extraction of the specific bioactive compounds that would have
inhibited of the pathogen. The zone of clearance of both the extracts against Escherichia coli was noted to be higher
than against other pathogens. This could be as a result of inadequate
extraction of the bioactive compounds by the solvent.
The minimum inhibitory concentration (MIC)
of the extracts were evaluated as seen in figure 2, and it was discovered that E. coli was inhibited by ethanol extract
at concentration of 12.5mg/ml and by aqueous extract it was inhibited at
25mg/ml. Klebsiella pneumonia was another pathogen that was
inhibited by methanol extratct at 25mg/ml. This
indicate that infection cause by E. coli
can be control by aqueous and methanol extracts of this plant specy. Klebsiella infection can
be control by methanol extract of the plant. At MIC of 50mg/ml both extracts
inhibited B. subtilist
and P. aeruginosa.
The minimum bactericidal concentration of
the extracts as seen in figure 3 indicate that E. coli was the only pathogen that was killed at lower
concentration at 25mg/ml followed by K. pneumoniae which was inhited
at 50mg/ml. Other pathogens were killed at concentration of 100ml.
CONCLUSION:
The
extracts demonstrated significant biological activity against the test
pathogenic organisms and this has introduced the plant as a potential candidate
for drug development for the treatment of diseases caused by these pathogens.
Of course, there would be the need to ascertain by further studies whether any
single or combination of the pure active metabolites would be better, safer and
more efficient in treating diseases caused by the selected pathogens than the
whole plant (crude extracts).
REFERENCES:
1. Afolayan AJ, Aliero
AA. Antimicrobial activity of solanum tomentosum. Afr. J. Biotech, 5(4)., 2006: 369 – 372.
2. Afoloyan AJ. Extacts
from the shoots of Aretotis arotoides
inhibit the growth of bacteria and fungi. Pharm. Biol
41 (1)., 2003: 22 – 25.
3. Ezekiel CN, Anokwuru
CP, Nsofor E, Odusanya OA, Adebanjo O. Antimicrobial Activity of the Methanolic and Crude Alkaloid Extracts of Acalyphawilkesiana cv. macafeeana
Copper Leaf. Research Journal of Microbiology, 4., 2009: 269-277.
4. Cowan, M.M. (1999). Plant
Products as Antimicrobial Agents clun. micro. Rev.,
12(4): 564-582.
5. Dharmananda S.: Gall nuts and the uses of
Tannins in Chinese Medicine. In: proceedings of institute for Traditional
Medicine, Portland, Oregon, 2003.
6. Gilman EF. Acalyphawilkesiana, Fact sheet FPS-6. University of
Florida Extension Service. pp: 1-3., 1999
7. Hammuel C, Abdullahi
MS, Mankilik M, Anyim BP, Adesina OB, Inekwe UV, Udiba UU, Batari ML. The phytochemical and antimicrobial activity of oil from the
seed of Thevetia peruviana
plant. Journal of Applied
Environmental and Biological Sciences, 1(12)., 2011: 597-601.
8. Hostettmann K., Marston A. Twenty years of research into medicinal plants: Results and
perspectives. Phytochem. Rev., 1., 2002: 275-285.
9. Iniaghe OM, Malomo
SO, Adebayo JO. Proximate
composition and phytochemical constituents of leaves
of some Acalypha species. Pakistan Journal of Nutrition 8., 2009: 256-258.
10. Iwu M. Hand book of
African Medical plants, CRE press Boca Raton, FL., pp, 27-44., 1993
11. Kirby GC. Medicinal
plants and the control of protozoal disease, with
particular reference to malaria. Trans. R. Soc. Trop. Med. Hyg.,
90.,1996: 605-609.
12. Maureer-Grimes B,
Macbeth DL, Hallihan B, and Delph
S. Antimicrobial activity of Medicinal Plants of the Scrophulariaceace
and Acanthaceace. International Journal
of Pharmacognosy 34 (4)., 1996: 243 – 248.
13. Oladunmoye MK.. Comparative
evaluation of antimicrobial activities and phytochemical
screening of two varieties of Acalyphawilkesiana.
Trends Applied Sci. Res., 1., 2006:538-541.
14.
Ravikumar PHS, Makari HK, Gurumurthy H. In vitro Antimicrobial Activity of
Ethanol Extract of Thevetia peruviana.
Electronic Journal of Environmental, Agriculture and Food Chemistry,
6(9)., 2007:.2318-2322.
15. Stephen UA, Abiodun
F, Osahon O, Ewaen E. Phytochemical analysis and antibacterial activity of Khayagrandifoliola stem bark. Journal of Biological Sciences, 9., 2009: 63-67.
16. Verastegui A, Verde J, Garcia S, Heredia
N, Oranday A., Rivas C. Species of Agave with antimicrobial activity
against selected pathogenic bacteria and fungi. World Journal of Microbial Biotechnology 24., 2008:1249-1252.
17. Yusha’u
M, Aliyu BS and Olonitola
SO. Preliminary screening of acalypha
extracts for in vitro inhibitory activity against extended-spectrum
β-lactamase producing enterobacteriaceae.
International Journal of Pure and Applied
Sciences 2., 2008:1-5
Received
on 20.05.2014 Modified on 12.07.2014
Accepted
on 19.07.2014 ©A&V Publications All right reserved
Res. J. Pharmacognosy & Phytochem.
6(3): July-Sept.2014; Page 118-121